READ OUR 2025 REPORT TO READERS

Recent Quotes
My Watchlist
Indicators
New Hampshire Stocks
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Guardant Health, Inc. - Common Stock (NQ:GH)

110.49 +0.56 (+0.51%)
Streaming Delayed Price Updated: 9:49 AM EST, Jan 8, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Guardant Health, Inc. - Common Stock

< Previous 1 2
...
13 14 15 16 17 18 19 20 Next >
News headline image
Earnings Outlook For Guardant Health ↗
 
Via Benzinga
News headline image
Guardant Health to Participate in Upcoming March Investor Conferences
From Guardant Health, Inc.
Via Business Wire
News headline image
25 AI Stocks to Buy Right Now ↗
Looking to benefit from the AI boom started by ChatGPT? Here are the best AI stocks to buy for the emerging market frenzy. 
Via InvestorPlace
News headline image
Guardant Health Initiates New Study to Examine the Impact of Shield™ Blood Test to Increase Screening Compliance for Colorectal Cancer
From Guardant Health, Inc.
Via Business Wire
News headline image
Guardant Health receives coverage from UnitedHealthcare for Guardant360® CDx blood test as companion diagnostic in advanced lung and breast cancer
From Guardant Health, Inc.
Via Business Wire
News headline image
Week In Review: Structure Stages $161 Million US IPO For AI/Structure-Based Drug Development ↗
Structure Therapeutics raised $161 million in a successful US IPO to support development of its oral therapeutics portfolio aimed at chronic metabolic and pulmonary diseases. Schrödinger is a... 
Via Talk Markets
News headline image
Guardant Health and AnHeart Therapeutics Announce Collaboration to Develop Guardant360® CDx and Guardant360 TissueNext™ as Companion Diagnostics for Taletrectinib in Advanced or Metastatic ROS1-Positive Non-Small Cell Lung Cancer
From Guardant Health Inc.
Via Business Wire
News headline image
Magistrate Judge Issues Favorable Recommendation Regarding Guardant Health’s Motion to Dismiss Lawsuit Brought by Illumina
From Guardant Health, Inc.
Via Business Wire
News headline image
Guardant Health to Report Fourth Quarter and Full Year 2022 Financial Results on February 23, 2023
From Guardant Health, Inc.
Via Business Wire
News headline image
Guardant Health introduces Guardant GalaxyTM suite of advanced AI analytics to enhance its portfolio of cancer tests and accelerate biomarker discovery
From Guardant Health, Inc.
Via Business Wire
News headline image
Guardant Health receives FDA approval for Guardant360® CDx as companion diagnostic for Menarini Group’s ORSERDU™ for treatment of patients with ESR1 mutations in ER+, HER2- advanced or metastatic breast cancer
From Guardant Health, Inc.
Via Business Wire
News headline image
Down 40% in 2022, Can Exact Sciences Recover in 2023? ↗
Investors are attracted to its leading position in the market for early cancer detection, but the persistent losses its been reporting are enough to make anyone nervous. 
Via The Motley Fool
News headline image
Guardant Health and The Royal Marsden NHS Foundation Trust partner on highly anticipated TRACC Part C trial to use Guardant Reveal™ blood test to help guide treatment decisions in colorectal cancer
From Guardant Health, Inc.
Via Business Wire
News headline image
Guardant Health to showcase new data at ASCO GI 2023 demonstrating utility of its blood tests for patients with gastrointestinal cancers
From Guardant Health, Inc.
Via Business Wire
News headline image
Cathie Wood Makes This Molecular Diagnostics Company Top Holding Of Ark Invest's Flagship Fund, Catapulting Past Zoom, Tesla ↗
Shares of Exact Sciences, Inc. (NASDAQ: EXAS) have been on a tear, having gained over 27% in two sessions this week. 
Via Benzinga
News headline image
Guardant Health Announces Preliminary Fourth Quarter and Full Year 2022 Results
From Guardant Health, Inc.
Via Business Wire
News headline image
Guardant Health to Participate in the 41st Annual J.P. Morgan Healthcare Conference
From Guardant Health, Inc.
Via Business Wire
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
News headline image
Guardant Health and Susan G. Komen® Partner to Develop Clinical Studies to Identify Early-Stage Breast Cancer Patients Who May Benefit From Additional Monitoring or Therapy
From Guardant Health, Inc.
Via Business Wire
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023 ↗
 
Via Benzinga
News headline image
Barron's Top Weekend Stock Picks: AMD, Ford, Accenture And Should Tesla CEO Elon Musk Be Replaced? ↗
Benzinga reviews this weekend's top stories covered by Barron's, here are the articles investors need to read. 
Via Benzinga
News headline image
Why Avaya Holdings Shares Are Trading Lower By 62%? Here Are 62 Stocks Moving In Friday's Mid-Day Session ↗
Gainers Allarity Therapeutics, Inc. (NASDAQ: ALLR) gained 240% to $0.90. Allarity Therapeutics, last month, posted a Q3 loss of $0.68 per share. 
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session ↗
 
Via Benzinga
News headline image
This Nasdaq Healthcare Stock's Pain Is Its Rival's Gain ↗
The broader market lost more ground on Friday. 
Via The Motley Fool
News headline image
AVYA Stock Alert: Is Avaya Holdings Nearing Bankruptcy? ↗
Avaya (AVYA) stock is falling hard on Friday following recent reports that the company is closing in on a bankruptcy filing. 
Via InvestorPlace
News headline image
Why Is Exact Sciences (EXAS) Stock Up 23% Today? ↗
Exact Sciences (EXAS) stock is on the rise Friday following news that Guardant Health's (GH) clinical trial didn't go as well as expected. 
Via InvestorPlace
News headline image
Guardant Health (GH) Stock Sinks on Disappointing Blood Test Results ↗
Guardant spent more money than it took in while hoping to become a leader in cancer diagnosis, but accuracy remains a problem. 
Via InvestorPlace
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Why Adobe Shares Are Trading Higher; Here Are 31 Stocks Moving Premarket ↗
Gainers Minim, Inc. (NASDAQ: MINM) shares rose 66.5% to $0.2903 in pre-market trading after gaining over 10% on Thursday. Minim, last month, reported worse-than-expected results. 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗
We're starting off the final trading day this week with a look at the biggest pre-market stock movers to watch for Friday! 
Via InvestorPlace
< Previous 1 2
...
13 14 15 16 17 18 19 20 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Gift this article